Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
New research, backed with $6 million in funding from the NIH, will seek to understand the fundamental mechanisms of schizophrenia.
10/1/2014 | 0 comments
A recent study by University of Rochester School of Medicine and Dentistry researchers published in the International Journal of Geriatric Psychiatry begins to unravel the relationship between metabolic syndrome, frailty and cognition. The authors found that having metabolic syndrome significantly increased the chances of becoming physically frailer and slower in cognitive abilities, such as slower in recalling something that happened half an hour ago.
6/4/2014 | 0 comments
HIV-associated brain damage occurs extensively, even in patients who are taking otherwise effective traditional anti-HIV therapy. This is a result of potent cooperation between two types of special immunological cells within the brain called monocytes and platelets. A recent paper published by University researchers in the Journal of Immunology demonstrates the presence of these platelet-monocyte ‘teams’ in HIV infected individuals and how these teams lead to increased neuronal damage.
6/3/2014 | 2 comments
A new mouse model of mild repetitive traumatic brain injury (TBI) – the sort of injury that can be common in sports such as football – could be the key to both understanding how this damage to the brain leads to neurological problems.
4/30/2014 | 1 comment
A perspective piece appearing today in the journal JAMA focuses on the challenges and opportunities arising from the increasing global incidence of neurological disorders. The authors advocate for new approaches that will increase access, lower costs, influence lifestyle changes, and create international research and clinical partnerships that address overlooked neurological conditions and underserved global populations.
4/22/2014 | 0 comments